Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LaserSight Excimer Laser Sales On Hold Pending Visx License Negotiations

This article was originally published in The Gray Sheet

Executive Summary

LaserSight says it will delay marketing of the LaserScan LSX ophthalmic excimer laser system in the U.S. while it negotiates a license agreement with competitor Visx.
Advertisement

Related Content

LaserSight LaserScan LSX For LASIK Myopia Correction To Ship By Year-End
LaserSight LaserScan LSX For LASIK Myopia Correction To Ship By Year-End
Visx v. Nidek ITC LASIK Ruling May Open Door For Bausch & Lomb, Others
Visx v. Nidek ITC LASIK Ruling May Open Door For Bausch & Lomb, Others
LaserSight's LaserScan LSX Will Be Sold By Six U.S. Direct Sales Reps
LaserSight's LaserScan LSX Will Be Sold By Six U.S. Direct Sales Reps
Advertisement
UsernamePublicRestriction

Register

MT012612

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel